Toxicological evaluation of sobatum

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 135-140

  Mohanan, P V ^a   Devi, K S ^b  

^a Toxicology Group   (India)

^b UNIVERSITY OF KERALA   (India)

Author keywords

Anticancer; Antioxidant enzymes; Histopathology; Solanum trilobatum; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ENZYME; PLANT EXTRACT; SITOSTEROL; SOBATUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; KIDNEY; LIVER; LUNG; MALE; MICE; PLANT EXTRACTS; SPLEEN;

ANIMALIA; SOLANUM; SOLANUM TRILOBATUM;

EID: 0032523856     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00022-6     Document Type: Article

References (21)

1. P.V. Mohanan, Toxicological/Safety Evaluation of an Anticancer Drug, Ph.D. Thesis, Kerala University, Kerala, 1996.
2. Mohanan P.V., Devi K.S. Cytotoxic potential of the preparations from Solanum trilobatum and the effect of sobatum on tumour reduction in mice. Cancer Lett. 110:1996;71-76.
3. Mohanan P.V., Devi K.S. Effect of sobatum on tumour development and chemically induced carcinogenesis. Cancer Lett. 112:1997;219-223.
4. Mohanan P.V., Rathinam K., Devi K.S. Effect of sobatum on ultra violet induced damage and superoxide production. Ind. J. Pharmacol. 29(2):1997;129-131.
5. Mohanan P.V., Devi K.S. Mutagenicity and antimutagenicity evaluation of sobatum by in vitro method. Biomedicine. 17(1):1997;9-15.
6. P.V. Mohanan, K.S. Devi, Chemoprotective effect of sobatum against cyclophosphamide toxicity in mice, J. Exp. Clin. Cancer Res. (1998), in press.
7. Mohanan P.V., Rathinam K., Devi K.S. Lack of micronucleus induction by sobatum in bone marrow erythrocytes of Swiss mice. Mutat. Res. 361:1996;23-27.
8. van den Heuvel M.J., Dayan A.D., Shillaker R.O. Evaluation of the BTS approach to the testing of substances and preparations for their toxicity. Hum. Toxicol. 6:1987;279.
9. J.A. Timbrell, Introduction to Toxicology, Taylor & Francis, London, 1989, pp. 129-139.
10. H. Varley, Practical Clinical Biochemistry, fifth ed., Heinemann, London, 1980, p. 741.
11. Benkey G.M., Cheever K.C. Comparative toxicity, anticholinesterase action and metabolism of methyl parathione and parathione in sun fish and mice. Toxicol. Appl. Pharmacol. 28:1974;97-109.
12. David M., Richard J.S. Glutathione reductase. Methods Enzymol. Anal. 3:1983;258-265.
13. Lawrence R.A., Burk L.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958.
14. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86:1978;271-278.
15. C.F.A. Culling, Handbook of Histopathological and Histochemical Techniques, third ed., Butterworths, Reading, MA, 1974.
16. William J.S., Daniel D., Von H. Taxol: a new effective anticancer drug. Anticancer Drugs. 2:1991;519-530.
17. Abe H., Wada M., Kohno K., Kuwano M. Altered drug sensitivities to anticancer agents in radiation sensitive DNA repair deficient yeast mutants. Anticancer Res. 14(5A):1994;1807-1810.
18. Chabot G.G. Factors involved in clinical pharmacology variability in oncology. Anticancer Res. 14(6A):1994;2269-2272.
19. Weiss A.J., Lackman R.D. Dose intensification by the simultaneous use of rhG-CSF and anticancer chemotherapy - clinical study. Int. J. Oncol. 6(2):1995;329-332.
20. Mehta R., Campbell J.S., Laver G.W., Stapley R., Mueller R. Acute hepatic response to aflatoxin B1 in rats fed a methyl deficient, amino acid defined diet. Cancer Lett. 69(2):1993;93-106.
21. S. Orrenius, H. Thor, G. Bellomo, P. Moldens, Proceedings of the IUPHAR 9th International Congress of Pharmacology 2 (1984) 57.